Catalyst Pharmaceuticals Gross Profit 2006-2020 | CPRX

Catalyst Pharmaceuticals gross profit from 2006 to 2020. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Catalyst Pharmaceuticals Annual Gross Profit
(Millions of US $)
2019 $88
2018 $1
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $0
2009 $
2008 $
2007 $
2006 $
2005 $
Catalyst Pharmaceuticals Quarterly Gross Profit
(Millions of US $)
2020-03-31 $25
2019-12-31 $26
2019-09-30 $27
2019-06-30 $25
2019-03-31 $11
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
2008-12-31
2008-09-30
2008-06-30
2008-03-31
2007-12-31
2007-09-30
2007-06-30
2007-03-31
2006-12-31
2006-09-30
2006-06-30
2006-03-31
2005-09-30
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.507B $0.102B
Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), anti-MuSK antibody positive myasthenia gravis (MuSK-MG), congenital myasthenic syndromes (CMS), and spinal muscular atrophy (SMA) Type 3.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.827B 37.36
Takeda Pharmaceutical (TAK) Japan $55.678B 9.76
Astellas Pharma (ALPMY) Japan $30.701B 15.56
Eisai (ESALY) Japan $23.773B 20.61
UCB SA (UCBJF) Belgium $23.292B 0.00
Merck (MKGAF) Germany $15.761B 20.67
Grifols, S.A (GRFS) Spain $13.098B 16.28
Neurocrine Biosciences (NBIX) United States $11.855B 54.79
Catalent (CTLT) United States $11.390B 44.03
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.467B 45.02
IPSEN SA ADR (IPSEY) France $7.290B 0.00
Orion OYJ (ORINY) Finland $6.978B 31.27
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.155B 9.85
United Therapeutics (UTHR) United States $5.239B 9.93
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.450B 485.78
Nektar Therapeutics (NKTR) United States $4.268B 0.00
Evotec AG (EVTCY) Germany $4.181B 112.67
FibroGen (FGEN) United States $3.843B 0.00
Hypermarcas (HYPMY) Brazil $3.838B 11.67
ChemoCentryx (CCXI) United States $3.578B 0.00
PTC Therapeutics (PTCT) United States $3.540B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.609B 10.72
Pacira BioSciences (PCRX) United States $2.285B 46.78
Cronos Group (CRON) Canada $2.250B 64.50
Sage Therapeutics (SAGE) United States $2.178B 0.00
Corcept Therapeutics (CORT) United States $1.916B 19.00
Xencor (XNCR) United States $1.867B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.743B 0.00
Akebia Therapeutics (AKBA) United States $1.702B 0.00
Indivior (INVVY) United States $1.679B 20.84
USANA Health Sciences (USNA) United States $1.672B 17.15
Ironwood Pharmaceuticals (IRWD) United States $1.637B 12.52
Zogenix (ZGNX) United States $1.609B 0.00
Karyopharm Therapeutics (KPTI) United States $1.431B 0.00
Esperion Therapeutics (ESPR) United States $1.404B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.401B 15.10
Heron Therapeutics (HRTX) United States $1.357B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.258B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.250B 0.00
Translate Bio (TBIO) United States $1.095B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.010B 45.09
Tilray (TLRY) Canada $0.980B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.873B 0.00
ImmunoGen (IMGN) United States $0.853B 0.00
Endo (ENDP) Ireland $0.830B 1.29
Radius Health (RDUS) United States $0.657B 0.00
Aerie Pharmaceuticals (AERI) United States $0.648B 0.00
Trillium Therapeutics (TRIL) Canada $0.635B 0.00
Molecular Templates (MTEM) United States $0.635B 0.00
Ardelyx (ARDX) United States $0.629B 0.00
Collegium Pharmaceutical (COLL) United States $0.602B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.573B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.568B 0.00
Flexion Therapeutics (FLXN) United States $0.505B 0.00
VAXART, INC (VXRT) United States $0.478B 0.00
Innate Pharma SA (IPHYF) France $0.476B 0.00
Siga Technologies (SIGA) United States $0.475B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.458B 17.85
DURECT (DRRX) United States $0.418B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.411B 0.00
Harpoon Therapeutics (HARP) United States $0.411B 0.00
Ocular Therapeutix (OCUL) United States $0.403B 0.00
TherapeuticsMD (TXMD) United States $0.397B 0.00
Organogenesis Holdings (ORGO) United States $0.386B 0.00
MEI Pharma (MEIP) United States $0.363B 0.00
Calithera Biosciences (CALA) United States $0.360B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.324B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.299B 0.00
Concert Pharmaceuticals (CNCE) United States $0.292B 0.00
Lannett Co Inc (LCI) United States $0.287B 6.29
PROFOUND MEDICL (PROF) Canada $0.274B 0.00
OptiNose (OPTN) United States $0.254B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.250B 0.00
CASI Pharmaceuticals (CASI) United States $0.249B 0.00
Redhill Biopharma (RDHL) Israel $0.244B 0.00
Taiwan Liposome (TLC) Taiwan $0.227B 0.00
KalVista Pharmaceuticals (KALV) United States $0.225B 0.00
Jounce Therapeutics (JNCE) United States $0.222B 5.29
Rafael Holdings (RFL) United States $0.222B 0.00
Nature's Sunshine Products (NATR) United States $0.183B 24.05
IMV INC (IMV) Canada $0.179B 0.00
Nivalis Therapeutics (ALPN) United States $0.177B 0.00
Aquestive Therapeutics (AQST) United States $0.159B 0.00
Altimmune (ALT) United States $0.154B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.153B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.136B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.121B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.106B 0.00
Recro Pharma (REPH) United States $0.105B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.104B 0.00
Xeris Pharmaceuticals (XERS) United States $0.104B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.102B 0.00
MediWound (MDWD) Israel $0.100B 0.00
Otonomy (OTIC) United States $0.098B 0.00
Onconova Therapeutics (ONTX) United States $0.098B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.092B 0.00
CTI BioPharma (CTIC) United States $0.088B 0.00
Sundial Growers (SNDL) Canada $0.087B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.086B 0.00
Hemispherx BioPharma (AIM) United States $0.082B 0.00
Biomerica (BMRA) United States $0.077B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
Heat Biologics (HTBX) United States $0.072B 0.00
Aclaris Therapeutics (ACRS) United States $0.070B 0.00
Lipocine (LPCN) United States $0.069B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.066B 0.00
CV Sciences (CVSI) United States $0.059B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Addex Therapeutics (ADXN) Switzerland $0.050B 0.00
Infinity Pharmaceuticals (INFI) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.45
PolarityTE (PTE) United States $0.049B 0.00
Natural Alternatives (NAII) United States $0.048B 0.00
Novan (NOVN) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Mannatechorporated (MTEX) United States $0.042B 7.87
Entasis Therapeutics Holdings (ETTX) United States $0.041B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.041B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.040B 0.00
GTx (ONCT) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 84.64
IsoRay (ISR) United States $0.039B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
AgeX Therapeutics (AGE) United States $0.033B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.032B 0.00
ElectroCore (ECOR) United States $0.031B 0.00
Jaguar Animal Health (JAGX) United States $0.029B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.027B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Flex Pharma (SLRX) United States $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
China SXT Pharmaceuticals (SXTC) China $0.016B 0.00
Can-Fite Biopharma (CANF) Israel $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 32.71
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Vical (BBI) United States $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00